Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.83 |
| ▸ | CPA3 | P15088 | 3/20 | 0.78 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.72 |
| ▸ | CPA1 | P15085 | 7/20 | 0.70 |
| ▸ | CPB1 | P15086 | 1/20 | 0.70 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.70 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.63 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.63 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.63 |
| ▸ | MME | P08473 | 1/20 | 0.59 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.58 |
| ▸ | ALPI | P09923 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | XIAP | P98170 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12494233 | 1.00 | CYP1A2 (0.83) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL6724759 | 1.00 | CYP1A2 (0.83) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| Hydrochloric Acid SCHEMBL6717346 | 0.98 | CYP1A2 (0.79) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL11664393 | 0.91 | FOLH1 (0.79) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL4664822 | 0.91 | CYP1A2 (1.00) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL12494839 | 0.90 | CYP1A2 (0.68) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL12494636 | 0.90 | CYP1A2 (0.68) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL12494703 | 0.90 | CYP1A2 (0.68) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL3276235 | 0.90 | CYP1A2 (0.68) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL12493651 | 0.90 | CYP1A2 (0.74) | CYP1A2CPA3FOLH1CPA1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351556-B2 | Process for the preparation of 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2s)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4YL] methyl} carbamoyl) amino]-4-(morpholin-4-yl)butanoyl]amino)-1,6-diphenylhexan-2-yl]carbamate | MSN LABORATORIES PRIVATE LIMITED (IN) | 2019-07-16 | — | — | US | disclosed |
| US-20180030043-A1 | NOVEL PROCESS FOR THE PREPARATION OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5- CARBAMOYL) AMINO] -4-(MORPHOLIN-4-YL)BUTANOYL]AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE | MSN LABORATORIES PRIVATE LIMITED (IN) | 2018-02-01 | — | — | US | disclosed |
| US-20180030043-A1 | NOVEL PROCESS FOR THE PREPARATION OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5- CARBAMOYL) AMINO] -4-(MORPHOLIN-4-YL)BUTANOYL]AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE | MSN LABORATORIES PRIVATE LIMITED (IN) | 2018-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351556-B2 | Process for the preparation of 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2s)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4YL] methyl} carbamoyl) amino]-4-(morpholin-4-yl)butanoyl]amino)-1,6-diphenylhexan-2-yl]carbamate | METTL3, CPS1, PKD1 | CYP1A2 1313/4885CPA3 2796/4885FOLH1 2131/4885 |
| US-20180030043-A1 | NOVEL PROCESS FOR THE PREPARATION OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5- CARBAMOYL) AMINO] -4-(MORPHOLIN-4-YL)BUTANOYL]AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE | CPS1, METTL3, ACMSD | CYP1A2 981/4885CPA3 2371/4885FOLH1 1887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.